TFS Capital’s Pulse Biosciences PLSE Stock Holding History

TFS Capital’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,019	Closed	-$286K	–	734
2017 Q1	$286K	Buy	+14,019	New	+$191K	0.09%	385

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TFS Capital's PLSE Position: Q2 2017 in Review

TFS Capital sold out of Pulse Biosciences (PLSE) in Q2 2017, closing a stake of 14,019 shares — an estimated $286K sold.

TFS Capital first reported a position in PLSE in Q1 2017 and held it in 1 quarter. The position peaked at $286K in Q1 2017. 49 funds tracked by Wall St. Rank hold PLSE as of Q2 2017.

TFS Capital reported no remaining Pulse Biosciences position as of Q2 2017 after selling out during the quarter.
TFS Capital sold 14,019 Pulse Biosciences shares in Q2 2017, an estimated $286K.
TFS Capital first reported a position in Pulse Biosciences in Q1 2017 and held it in 1 quarter.
TFS Capital's Pulse Biosciences position peaked at $286K in Q1 2017.
49 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.